| Molecular Formula | C19H12ClNO6S |
| Molar Mass | 417.82 |
| Density | 1.466±0.06 g/cm3(Predicted) |
| Boling Point | 664.8±55.0 °C(Predicted) |
| Solubility | DMSO: ≥ 47 mg/mL |
| Storage Condition | -20℃ |
| In vitro study | BTB06584 inhibits F1 Fo-ATPase activity in an if1-dependent manner, has no effect on ATP synthesis, and limits the ischemia-induced damage caused by mitochondrial F1 Fo-ATP synthase inversion. |
| In vivo study | BTB06584 restores defective hemoglobin synthesis in zebrafish pintage (pnt) mutants without causing significant toxicity. |
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 2.393 ml | 11.967 ml | 23.934 ml |
| 5 mM | 0.479 ml | 2.393 ml | 4.787 ml |
| 10 mM | 0.239 ml | 1.197 ml | 2.393 ml |
| 5 mM | 0.048 ml | 0.239 ml | 0.479 ml |